MACKAY SHIELDS LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 12 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MACKAY SHIELDS LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q2 2021$110,000
+5.8%
110,0000.0%0.00%0.0%
Q1 2021$104,000
+1.0%
110,0000.0%0.00%0.0%
Q4 2020$103,0000.0%110,0000.0%0.00%0.0%
Q3 2020$103,000
+2.0%
110,0000.0%0.00%0.0%
Q2 2020$101,000
+3.1%
110,0000.0%0.00%0.0%
Q1 2020$98,000
+2.1%
110,0000.0%0.00%0.0%
Q4 2019$96,000
-82.5%
110,000
-82.5%
0.00%
-66.7%
Q3 2019$550,000
-2.1%
630,0000.0%0.00%
-25.0%
Q2 2019$562,000
+15.6%
630,000
+21.2%
0.00%0.0%
Q1 2019$486,000
-29.9%
520,000
-37.0%
0.00%
-33.3%
Q4 2018$693,000
-10.5%
825,0000.0%0.01%0.0%
Q3 2018$774,000
-13.1%
825,0000.0%0.01%0.0%
Q2 2018$891,000
+16.0%
825,000
+25.0%
0.01%
+20.0%
Q1 2018$768,000
-13.8%
660,0000.0%0.01%
-84.8%
Q4 2017$891,000
+60.0%
660,000
+83.3%
0.03%
+57.1%
Q3 2017$557,000360,0000.02%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
LINDEN ADVISORS LP 69,346,000$107,321,0003.81%
PFM Health Sciences, LP 34,710,000$53,670,0001.06%
Partner Investment Management, L.P. 556,000$860,0000.82%
Myriad Asset Management Ltd. 5,000,000$7,731,0000.75%
SYMPHONY ASSET MANAGEMENT LLC 4,000,000$6,185,0000.69%
CAPSTONE INVESTMENT ADVISORS, LLC 9,074,000$14,030,0000.49%
CSS LLC/IL 5,251,000$8,112,0000.40%
SSI INVESTMENT MANAGEMENT LLC 2,813,000$4,333,0000.37%
ADVENT CAPITAL MANAGEMENT /DE/ 7,131,000$11,056,0000.21%
D. E. Shaw & Co., Inc. 27,750,000$42,835,0000.07%
View complete list of CLOVIS ONCOLOGY INC shareholders